AI-generated summary
The authors studied photobiomodulation therapy at three energy densities in 48 male rats with induced rheumatoid arthritis, comparing it with methotrexate and untreated controls. They report that all light-treated groups showed reduced paw thickness and inflammatory markers, with 54 J/cm2 showing the strongest effect, comparable to methotrexate. Because the study was done in rats, its relevance to human patients is uncertain.
- Participants
- 48
- Who or what was studied
- Male rats with induced rheumatoid arthritis
- Limits stated in the abstract
- The study was conducted in rats, so findings may not apply to humans, and the abstract does not report wavelengths or the treatment duration.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Energy density (fluence)
- 36 J/cm2, 54 J/cm2, 72 J/cm2
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Oxidative stress, Inflammation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.